SCHEMBL24314292

SCHEMBL24314292

CC(C)c1ccc(OCC2CC2(F)F)c(SN)c1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 18/20 0.37
▸ BRD4 O60885 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24314212 0.87 ACACB (0.39) ACACBBRD4
SCHEMBL17811813 0.81 ACACB (0.39) ACACB
SCHEMBL24313917 0.81 PDE4B (0.38) —
SCHEMBL17811838 0.80 ACACB (0.41) ACACB
SCHEMBL24313897 0.80 ACACB (0.38) ACACB
SCHEMBL29469892 0.80 ACACB (0.38) ACACB
SCHEMBL13091261 0.79 ACACB (0.41) ACACB
SCHEMBL20820450 0.78 FFAR4 (0.37) ACACB
SCHEMBL22587894 0.78 ALDH1A1 (0.41) ACACBBRD4
SCHEMBL29588404 0.78 ALDH1A1 (0.41) ACACBBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 — — WO disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 — — WO disclosed
Send feedback